The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insulin Injection Devices Market Research Report 2024
Synopsis
Global Insulin Injection Devices market is projected to reach US$ 14500 million in 2030, increasing from US$ 11340 million in 2023, with the CAGR of 3.7% during the period of 2024 to 2030.
The driving factors for insulin injection equipment mainly include the following aspects:
Growth in the prevalence of diabetes: As the prevalence of diabetes continues to grow globally, the number of patients requiring insulin treatment is also increasing, which directly drives the market demand for insulin injection equipment.
Need for Insulin Treatment: Insulin is an important drug in the treatment of diabetes and requires regular injections to control blood sugar levels. Therefore, the demand for insulin injection equipment is also increasing.
Convenience and safety of disposable needles: The use of disposable needles reduces the risk of infection, is easy to handle, and is convenient to carry, which makes them popular in the insulin injection equipment market.
Advances in medical technology: With the continuous advancement of medical technology, insulin injection equipment is also constantly improving and innovating, improving the convenience and safety of use, further promoting market demand.
Report Scope
This report, based on historical analysis (2019-2023) and forecast calculation (2024-2030), aims to help readers to get a comprehensive understanding of global Insulin Injection Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Apex Medical
BD
Tonghua Dongbao Pharmaceutical
Eli Lilly
Biocon Ltd
Ganlee
Insulet
LenoMed Medical
Maishitong
Medtronic
MicroTech Medical
Novo Nordisk
Owen Mumford
Zhengzhou Phray Technology
Sanofi
SOOIL
Tandem
Ypsomed Holding
Abbott Laboratories
FORNIA
Segment by Type
Insulin Pump
Insulin Pen
Insulin Syringe
Others
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Insulin Injection Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Insulin Injection Devices market is projected to reach US$ 14500 million in 2030, increasing from US$ 11340 million in 2023, with the CAGR of 3.7% during the period of 2024 to 2030.
The driving factors for insulin injection equipment mainly include the following aspects:
Growth in the prevalence of diabetes: As the prevalence of diabetes continues to grow globally, the number of patients requiring insulin treatment is also increasing, which directly drives the market demand for insulin injection equipment.
Need for Insulin Treatment: Insulin is an important drug in the treatment of diabetes and requires regular injections to control blood sugar levels. Therefore, the demand for insulin injection equipment is also increasing.
Convenience and safety of disposable needles: The use of disposable needles reduces the risk of infection, is easy to handle, and is convenient to carry, which makes them popular in the insulin injection equipment market.
Advances in medical technology: With the continuous advancement of medical technology, insulin injection equipment is also constantly improving and innovating, improving the convenience and safety of use, further promoting market demand.
Report Scope
This report, based on historical analysis (2019-2023) and forecast calculation (2024-2030), aims to help readers to get a comprehensive understanding of global Insulin Injection Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Apex Medical
BD
Tonghua Dongbao Pharmaceutical
Eli Lilly
Biocon Ltd
Ganlee
Insulet
LenoMed Medical
Maishitong
Medtronic
MicroTech Medical
Novo Nordisk
Owen Mumford
Zhengzhou Phray Technology
Sanofi
SOOIL
Tandem
Ypsomed Holding
Abbott Laboratories
FORNIA
Segment by Type
Insulin Pump
Insulin Pen
Insulin Syringe
Others
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Insulin Injection Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Insulin Injection Devices Market Overview
1.1 Product Overview and Scope of Insulin Injection Devices
1.2 Insulin Injection Devices Segment by Type
1.2.1 Global Insulin Injection Devices Market Value Comparison by Type (2024-2030)
1.2.2 Insulin Pump
1.2.3 Insulin Pen
1.2.4 Insulin Syringe
1.2.5 Others
1.3 Insulin Injection Devices Segment by Application
1.3.1 Global Insulin Injection Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Insulin Injection Devices Market Size Estimates and Forecasts
1.4.1 Global Insulin Injection Devices Revenue 2019-2030
1.4.2 Global Insulin Injection Devices Sales 2019-2030
1.4.3 Global Insulin Injection Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Injection Devices Market Competition by Manufacturers
2.1 Global Insulin Injection Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Injection Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Injection Devices Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Injection Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Injection Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Injection Devices, Product Type & Application
2.7 Insulin Injection Devices Market Competitive Situation and Trends
2.7.1 Insulin Injection Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Injection Devices Players Market Share by Revenue
2.7.3 Global Insulin Injection Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Injection Devices Retrospective Market Scenario by Region
3.1 Global Insulin Injection Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Injection Devices Global Insulin Injection Devices Sales by Region: 2019-2030
3.2.1 Global Insulin Injection Devices Sales by Region: 2019-2024
3.2.2 Global Insulin Injection Devices Sales by Region: 2025-2030
3.3 Global Insulin Injection Devices Global Insulin Injection Devices Revenue by Region: 2019-2030
3.3.1 Global Insulin Injection Devices Revenue by Region: 2019-2024
3.3.2 Global Insulin Injection Devices Revenue by Region: 2025-2030
3.4 North America Insulin Injection Devices Market Facts & Figures by Country
3.4.1 North America Insulin Injection Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Injection Devices Sales by Country (2019-2030)
3.4.3 North America Insulin Injection Devices Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Injection Devices Market Facts & Figures by Country
3.5.1 Europe Insulin Injection Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Injection Devices Sales by Country (2019-2030)
3.5.3 Europe Insulin Injection Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Injection Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Injection Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Injection Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Injection Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insulin Injection Devices Market Facts & Figures by Country
3.7.1 Latin America Insulin Injection Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Injection Devices Sales by Country (2019-2030)
3.7.3 Latin America Insulin Injection Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Insulin Injection Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Injection Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Injection Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Injection Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Injection Devices Sales by Type (2019-2030)
4.1.1 Global Insulin Injection Devices Sales by Type (2019-2024)
4.1.2 Global Insulin Injection Devices Sales by Type (2025-2030)
4.1.3 Global Insulin Injection Devices Sales Market Share by Type (2019-2030)
4.2 Global Insulin Injection Devices Revenue by Type (2019-2030)
4.2.1 Global Insulin Injection Devices Revenue by Type (2019-2024)
4.2.2 Global Insulin Injection Devices Revenue by Type (2025-2030)
4.2.3 Global Insulin Injection Devices Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Injection Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Injection Devices Sales by Application (2019-2030)
5.1.1 Global Insulin Injection Devices Sales by Application (2019-2024)
5.1.2 Global Insulin Injection Devices Sales by Application (2025-2030)
5.1.3 Global Insulin Injection Devices Sales Market Share by Application (2019-2030)
5.2 Global Insulin Injection Devices Revenue by Application (2019-2030)
5.2.1 Global Insulin Injection Devices Revenue by Application (2019-2024)
5.2.2 Global Insulin Injection Devices Revenue by Application (2025-2030)
5.2.3 Global Insulin Injection Devices Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Injection Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Apex Medical
6.1.1 Apex Medical Corporation Information
6.1.2 Apex Medical Description and Business Overview
6.1.3 Apex Medical Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Apex Medical Insulin Injection Devices Product Portfolio
6.1.5 Apex Medical Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Insulin Injection Devices Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Tonghua Dongbao Pharmaceutical
6.3.1 Tonghua Dongbao Pharmaceutical Corporation Information
6.3.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.3.3 Tonghua Dongbao Pharmaceutical Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tonghua Dongbao Pharmaceutical Insulin Injection Devices Product Portfolio
6.3.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Insulin Injection Devices Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Biocon Ltd
6.5.1 Biocon Ltd Corporation Information
6.5.2 Biocon Ltd Description and Business Overview
6.5.3 Biocon Ltd Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biocon Ltd Insulin Injection Devices Product Portfolio
6.5.5 Biocon Ltd Recent Developments/Updates
6.6 Ganlee
6.6.1 Ganlee Corporation Information
6.6.2 Ganlee Description and Business Overview
6.6.3 Ganlee Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ganlee Insulin Injection Devices Product Portfolio
6.6.5 Ganlee Recent Developments/Updates
6.7 Insulet
6.6.1 Insulet Corporation Information
6.6.2 Insulet Description and Business Overview
6.6.3 Insulet Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Insulet Insulin Injection Devices Product Portfolio
6.7.5 Insulet Recent Developments/Updates
6.8 LenoMed Medical
6.8.1 LenoMed Medical Corporation Information
6.8.2 LenoMed Medical Description and Business Overview
6.8.3 LenoMed Medical Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LenoMed Medical Insulin Injection Devices Product Portfolio
6.8.5 LenoMed Medical Recent Developments/Updates
6.9 Maishitong
6.9.1 Maishitong Corporation Information
6.9.2 Maishitong Description and Business Overview
6.9.3 Maishitong Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Maishitong Insulin Injection Devices Product Portfolio
6.9.5 Maishitong Recent Developments/Updates
6.10 Medtronic
6.10.1 Medtronic Corporation Information
6.10.2 Medtronic Description and Business Overview
6.10.3 Medtronic Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medtronic Insulin Injection Devices Product Portfolio
6.10.5 Medtronic Recent Developments/Updates
6.11 MicroTech Medical
6.11.1 MicroTech Medical Corporation Information
6.11.2 MicroTech Medical Insulin Injection Devices Description and Business Overview
6.11.3 MicroTech Medical Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MicroTech Medical Insulin Injection Devices Product Portfolio
6.11.5 MicroTech Medical Recent Developments/Updates
6.12 Novo Nordisk
6.12.1 Novo Nordisk Corporation Information
6.12.2 Novo Nordisk Insulin Injection Devices Description and Business Overview
6.12.3 Novo Nordisk Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novo Nordisk Insulin Injection Devices Product Portfolio
6.12.5 Novo Nordisk Recent Developments/Updates
6.13 Owen Mumford
6.13.1 Owen Mumford Corporation Information
6.13.2 Owen Mumford Insulin Injection Devices Description and Business Overview
6.13.3 Owen Mumford Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Owen Mumford Insulin Injection Devices Product Portfolio
6.13.5 Owen Mumford Recent Developments/Updates
6.14 Zhengzhou Phray Technology
6.14.1 Zhengzhou Phray Technology Corporation Information
6.14.2 Zhengzhou Phray Technology Insulin Injection Devices Description and Business Overview
6.14.3 Zhengzhou Phray Technology Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhengzhou Phray Technology Insulin Injection Devices Product Portfolio
6.14.5 Zhengzhou Phray Technology Recent Developments/Updates
6.15 Sanofi
6.15.1 Sanofi Corporation Information
6.15.2 Sanofi Insulin Injection Devices Description and Business Overview
6.15.3 Sanofi Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sanofi Insulin Injection Devices Product Portfolio
6.15.5 Sanofi Recent Developments/Updates
6.16 SOOIL
6.16.1 SOOIL Corporation Information
6.16.2 SOOIL Insulin Injection Devices Description and Business Overview
6.16.3 SOOIL Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 SOOIL Insulin Injection Devices Product Portfolio
6.16.5 SOOIL Recent Developments/Updates
6.17 Tandem
6.17.1 Tandem Corporation Information
6.17.2 Tandem Insulin Injection Devices Description and Business Overview
6.17.3 Tandem Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tandem Insulin Injection Devices Product Portfolio
6.17.5 Tandem Recent Developments/Updates
6.18 Ypsomed Holding
6.18.1 Ypsomed Holding Corporation Information
6.18.2 Ypsomed Holding Insulin Injection Devices Description and Business Overview
6.18.3 Ypsomed Holding Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Ypsomed Holding Insulin Injection Devices Product Portfolio
6.18.5 Ypsomed Holding Recent Developments/Updates
6.19 Abbott Laboratories
6.19.1 Abbott Laboratories Corporation Information
6.19.2 Abbott Laboratories Insulin Injection Devices Description and Business Overview
6.19.3 Abbott Laboratories Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Abbott Laboratories Insulin Injection Devices Product Portfolio
6.19.5 Abbott Laboratories Recent Developments/Updates
6.20 FORNIA
6.20.1 FORNIA Corporation Information
6.20.2 FORNIA Insulin Injection Devices Description and Business Overview
6.20.3 FORNIA Insulin Injection Devices Sales, Revenue and Gross Margin (2019-2024)
6.20.4 FORNIA Insulin Injection Devices Product Portfolio
6.20.5 FORNIA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Injection Devices Industry Chain Analysis
7.2 Insulin Injection Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Injection Devices Production Mode & Process
7.4 Insulin Injection Devices Sales and Marketing
7.4.1 Insulin Injection Devices Sales Channels
7.4.2 Insulin Injection Devices Distributors
7.5 Insulin Injection Devices Customers
8 Insulin Injection Devices Market Dynamics
8.1 Insulin Injection Devices Industry Trends
8.2 Insulin Injection Devices Market Drivers
8.3 Insulin Injection Devices Market Challenges
8.4 Insulin Injection Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
